Influenza Vaccine in Pediatric Recipients of Hematopoietic-Cell Transplants.
作者信息
Schuster Jennifer E, Hamdan Lubna, Dulek Daniel E, Kitko Carrie L, Batarseh Einas, Haddadin Zaid, Stewart Laura S, Stahl Anna, Potter Molly, Rahman Herdi, Kalams Spyros A, Coffin Susan, Ardura Monica I, Wattier Rachel L, Maron Gabriela, Bocchini Claire E, Moulton Elizabeth A, Grimley Michael, Paulsen Grant, Harrison Christopher J, Freedman Jason, Carpenter Paul A, Englund Janet A, Munoz Flor M, Danziger-Isakov Lara, Spieker Andrew J, Halasa Natasha
机构信息
Children's Mercy Kansas City, Kansas City, MO.
Vanderbilt University Medical Center, Nashville, TN.
出版信息
N Engl J Med. 2023 Jan 26;388(4):374-376. doi: 10.1056/NEJMc2210825. Epub 2023 Jan 11.
Abstract
摘要
相似文献
1
Influenza Vaccine in Pediatric Recipients of Hematopoietic-Cell Transplants.
N Engl J Med. 2023 Jan 26;388(4):374-376. doi: 10.1056/NEJMc2210825. Epub 2023 Jan 11.
2
Influenza vaccination in hematopoietic SCT recipients.
Bone Marrow Transplant. 2008 Nov;42(10):637-41. doi: 10.1038/bmt.2008.264. Epub 2008 Aug 25.
3
Immunophenotypic predictors of influenza vaccine immunogenicity in pediatric hematopoietic cell transplant recipients.
Blood Adv. 2024 Apr 23;8(8):1880-1892. doi: 10.1182/bloodadvances.2023012118.
4
The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic.
Vaccine. 2011 Feb 17;29(9):1777-82. doi: 10.1016/j.vaccine.2010.12.113. Epub 2011 Jan 7.
5
Vaccines for preventing influenza in healthy children.
Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD004879. doi: 10.1002/14651858.CD004879.pub4.
6
Vaccines for preventing influenza in healthy children.
Cochrane Database Syst Rev. 2006 Jan 25(1):CD004879. doi: 10.1002/14651858.CD004879.pub2.
7
Vaccines for preventing influenza in healthy children.
Cochrane Database Syst Rev. 2008 Apr 16(2):CD004879. doi: 10.1002/14651858.CD004879.pub3.
8
Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients.
Vaccine. 2014 Jan 23;32(5):585-91. doi: 10.1016/j.vaccine.2013.11.073. Epub 2013 Dec 12.
9
Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials.
Vaccine. 2012 Dec 17;31(1):49-57. doi: 10.1016/j.vaccine.2012.10.084. Epub 2012 Nov 7.
10
Shorter duration of protection and lower geometric mean titers against A/H3N2 antigen of the quadrivalent influenza vaccine in children post-allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant. 2022 Oct;57(10):1620-1622. doi: 10.1038/s41409-022-01768-6. Epub 2022 Aug 1.
引用本文的文献
1
Boosting the influenza vaccine schedule in children with cancer: a prospective open-label study.
NPJ Vaccines. 2025 Aug 26;10(1):203. doi: 10.1038/s41541-025-01256-0.
2
Recent advances in the influenza virus vaccine landscape: a comprehensive overview of technologies and trials.
Clin Microbiol Rev. 2024 Dec 10;37(4):e0002524. doi: 10.1128/cmr.00025-24. Epub 2024 Oct 3.
3
Immunogenicity and Reactogenicity of High- or Standard-Dose Influenza Vaccine in a Second Consecutive Influenza Season.
J Infect Dis. 2025 Feb 4;231(1):e123-e131. doi: 10.1093/infdis/jiae454.
4
Comparison of Two High-Dose Versus Two Standard-Dose Influenza Vaccines in Adult Allogeneic Hematopoietic Cell Transplant Recipients.
Clin Infect Dis. 2023 Dec 15;77(12):1723-1732. doi: 10.1093/cid/ciad458.
5
Vaccination of Adults With Cancer: ASCO Guideline.
J Clin Oncol. 2024 May 10;42(14):1699-1721. doi: 10.1200/JCO.24.00032. Epub 2024 Mar 18.
6
Impact of Respiratory Viral Infections in Transplant Recipients.
J Pediatric Infect Dis Soc. 2024 Feb 28;13(Supplement_1):S39-S48. doi: 10.1093/jpids/piad094.
7
Immunophenotypic predictors of influenza vaccine immunogenicity in pediatric hematopoietic cell transplant recipients.
Blood Adv. 2024 Apr 23;8(8):1880-1892. doi: 10.1182/bloodadvances.2023012118.
8
The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial.
Clin Infect Dis. 2024 Jan 25;78(1):217-226. doi: 10.1093/cid/ciad534.
9
Vaccine schedule recommendations and updates for patients with hematologic malignancy post-hematopoietic cell transplant or CAR T-cell therapy.
Transpl Infect Dis. 2023 Nov;25 Suppl 1(Suppl 1):e14109. doi: 10.1111/tid.14109. Epub 2023 Jul 29.
本文引用的文献
1
Immunogenicity of the inactivated influenza vaccine in children who have undergone allogeneic haematopoietic stem cell transplant.
Bone Marrow Transplant. 2020 Apr;55(4):773-779. doi: 10.1038/s41409-019-0728-5. Epub 2019 Oct 28.
2
Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Hematopoietic Stem Cell Transplantation Patients.
Biol Blood Marrow Transplant. 2016 Mar;22(3):528-35. doi: 10.1016/j.bbmt.2015.12.003. Epub 2015 Dec 17.
3
Randomized, double-blind comparison of standard-dose vs. high-dose trivalent inactivated influenza vaccine in pediatric solid organ transplant patients.
Pediatr Transplant. 2015 Mar;19(2):219-28. doi: 10.1111/petr.12419. Epub 2014 Dec 18.
4
Safety of high dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia.
Pediatr Blood Cancer. 2014 May;61(5):815-20. doi: 10.1002/pbc.24863. Epub 2013 Nov 19.
Zotero 插件